Genewel Co., Ltd.
Genewel Co., Ltd., one of subsidiary companies of Dongsung Holdings Co., Ltd (Chemical + Bio Medical + Green Energy) is considered not only as a pioneer of Anti-adhesion Guardix-sol® and Wound dressing Medifoam® in Korean market but also as a market leader since 2005.With 20% average annual growth, Genewel’s key products hold a strong position in 2011 as below: Advanced Wound Care Market Share : 74% in US$17milion Adhesion Barrier Market Share : 66% in US$25million As a global bio-medical company, we are constantly devoting ourselves on Research & Development in betterment of bio-medical industry for the forthcoming years.
Company Introduction
Genewel Co., Ltd., one of subsidiary companies of Dongsung Holdings Co., Ltd (Chemical + Bio Medical + Green Energy) is considered not only as a pioneer of Anti-adhesion Guardix-sol® and Wound dressing Medifoam® in Korean market but also as a market leader since 2005.
With 20% average annual growth, Genewel’s key products hold a strong position in 2011 as below:
- Advanced Wound Care Market Share : 74% in US$17milion
- Adhesion Barrier Market Share : 66% in US$25million
As a global bio-medical company, we are constantly devoting ourselves on Research & Development in betterment of bio-medical industry for the forthcoming years.
Detailed Company Information
Genewel Co., Ltd.
- Business Type
- Year Established
- Location South Korea
- Main Markets China,Germany,Indonesia,Iran,Japan,South Korea
- Total Employees 101-500 People
- Homepage www.genewel.com
- President Byung Hyun Moon
- Phone +82-31-8018-5500
- FAX +82-31-8018-5520
- Address 6F, 37, Sagimakgol-ro 62 beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea
- Product Category Beauty & Personal Care
- Factory Information Genewel Co., Ltd. 6F, 37, Sagimakgol-ro 62 beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea
Additional Introduction
Genewel Co., Ltd. is considered not only as a pioneer of Anti- adhesion & Wound care products in Korean market but also as a market leader since launching those two products due to intensively concentrating R&D and human resources to propel our goal of leadership in Bio Medical sector.